Personnaliser

OK

Informations importantes : Arrêt du Club R (13 août) et Cessation d'Activité (30 septembre)

En savoir plus.

Leading Pharmaceutical Innovation - Gassmann, Oliver

Note : 0

0 avis
  • Soyez le premier à donner un avis
Filtrer par :

121,82 €

Produit Neuf

  • Ou 30,46 € /mois

    • Livraison à 0,01 €
    • Livré entre le 26 août et le 11 septembre
    Voir les modes de livraison

    RiaChristie

    PRO Vendeur favori

    4,9/5 sur + de 1 000 ventes

    Brand new, In English, Fast shipping from London, UK; Tout neuf, en anglais, expédition rapide depuis Londres, Royaume-Uni;ria9783319668321_dbm

    Nos autres offres

    • 128,85 €

      Produit Neuf

      Ou 32,21 € /mois

      • Livraison : 3,99 €
      • Livré entre le 26 août et le 2 septembre
      Voir les modes de livraison
      4,8/5 sur + de 1 000 ventes
      Voir le détail de l'annonce 
    Publicité
     
    Vous avez choisi le retrait chez le vendeur à
    • Payez directement sur Rakuten (CB, PayPal, 4xCB...)
    • Récupérez le produit directement chez le vendeur
    • Rakuten vous rembourse en cas de problème

    Gratuit et sans engagement

    Félicitations !

    Nous sommes heureux de vous compter parmi nos membres du Club Rakuten !

    En savoir plus

    Retour

    Horaires

        Note :


        Avis sur Leading Pharmaceutical Innovation Format Relié  - Livre Économie

        Note : 0 0 avis sur Leading Pharmaceutical Innovation Format Relié  - Livre Économie

        Les avis publiés font l'objet d'un contrôle automatisé de Rakuten.


        Présentation Leading Pharmaceutical Innovation Format Relié

         - Livre Économie

        Livre Économie - Gassmann, Oliver - 01/05/2018 - Relié - Langue : Anglais

        . .

      • Auteur(s) : Gassmann, Oliver - Reepmeyer, Gerrit - Zedtwitz, Max Von - Schuhmacher, Alexander
      • Editeur : Springer International Publishing Ag
      • Langue : Anglais
      • Parution : 01/05/2018
      • Format : Moyen, de 350g à 1kg
      • Nombre de pages : 196.0
      • ISBN : 9783319668321



      • Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies, aimed at generating sustainable competitive advantage for its protagonists based

        Biographie:
        Prof. Dr. Oliver Gassmann is professor of technology management at the University of St. Gallen (Switzerland), and managing director of the Institute of Technology Management. After completing his PhD in 1996, he was head of corporate research at Schindler. He published over 400 papers in leading international management journals. In 2014, he was awarded the Scholary Impact Award by the Journal of Management, and in 2015 with the Citation Excellence Award of the Emerald Group. He also serves as a founder and advisor on several boards. Prof. Dr. Alexander Schuhmacher is professor at Reutlingen University (Germany). He teaches in business management and medical science. He officiates as Senator of Reutlingen University and he also serves as managing director of the Knowledge Foundation @ Reutlingen University. He worked for 14 years in various R&D positions in the pharmaceutical industry. As member of Nycomed's senior R&D management team, he headed the StrategicPlanning & Business Support function and co-headed the R&D integration team following the merger of Nycomed and ALTANA Pharma. Prof. Dr. Max von Zedtwitz is professor at Kaunas University of Technology (Lithuania), and director of the GLORAD Center for Global R&D and Innovation. Previously he was a professor at Tsinghua, Peking University, Skoltech, and IMD, and a vice president at PRTM. In 2009 he was recognized by IAMOT as one of the fifty most influential innovation scholars worldwide. A frequent public speaker, he has appeared on television, and has been cited in the Economist, China Daily, the South China Morning Post and the New York Times. Dr. Gerrit Reepmeyer is co-founder & COO of Guardhat Inc., a startup based in Detroit (USA). Prior to that, he held various executive leadership positions in industrial and technology companies. He started his career in management consulting with McKinsey & Company. He has a PhD degree from the University of St. Gallen and was a research scholar at Columbia University in New York. He co-authored several books and publications on technology management, and he is co-inventor of five patents....

        Détails de conformité du produit

        Consulter les détails de conformité de ce produit (

        Personne responsable dans l'UE

        )
        Le choixNeuf et occasion
        Le service clientsÀ votre écoute
        LinkedinFacebookTwitterInstagramYoutubePinterestTiktok
        visavisa
        mastercardmastercard
        klarnaklarna
        paypalpaypal
        floafloa
        americanexpressamericanexpress
        Rakuten Logo
        • Rakuten Kobo
        • Rakuten TV
        • Rakuten Viber
        • Rakuten Viki
        • Plus de services
        • À propos de Rakuten
        Rakuten.com